Paratek Pharmaceuticals Inc

MORGAN STANLEY

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

111,434

Value ($000)

246

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	246	0.0%	111,434	6/30/2023
2023 Q1	5/15/2023	805	0.0%	316,848	3/31/2023
2022 Q4	2/14/2023	263	0.0%	140,732	12/31/2022
2022 Q3	11/14/2022	505	0.0%	196,690	9/30/2022
2022 Q2	10/27/2022	405	0.0%	209,244	6/30/2022
2022 Q1	10/27/2022	286	0.0%	96,626	3/31/2022
2021 Q4	2/14/2022	340	0.0%	75,771	12/31/2021
2021 Q3	11/15/2021	795	0.0%	163,833	9/30/2021
2021 Q2	8/23/2021	1,020	0.0%	149,659	6/30/2021
2021 Q1	5/17/2021	1,671	0.0%	236,802	3/31/2021
2020 Q4	2/16/2021	684	0.0%	109,273	12/31/2020
2020 Q3	11/13/2020	2,956	0.0%	546,456	9/30/2020
2020 Q2	8/14/2020	3,574	0.0%	684,823	6/30/2020
2020 Q1	5/26/2020	99	0.0%	31,172	3/31/2020
2019 Q4	2/14/2020	252	0.0%	62,540	12/31/2019